Investing.com -- U.S. futures traded higher Wednesday, as investors digested more corporate earnings, particularly from the retail sector, ahead of the release of numbers from chip designer Nvidia (NASDAQ: NVDA ).
Here are some of the biggest premarket U.S. stock movers today:
Kohl’s (NYSE: KSS ) stock rose 3.5% after the department store operator beat quarterly profit estimates, as leaner inventories, lower costs, and fewer discounts helped to counter a broader retail slowdown.
Foot Locker (NYSE: FL ) stock slumped 31.4% after the sportswear retailer reported another quarter of falling sales, paused quarterly dividends, and slashed its outlook for the second time this year, blaming “consumer softness.”
- Peloton (NASDAQ: PTON ) stock slumped 25.7% after the exercise bike retailer forecast first quarter revenue below estimates as a shift in consumer spending toward travel and experiences hurt demand for its equipment.
- Bath & Body Works (NYSE: BBWI ) stock fell 2.7% after the specialty retailer warned of a steeper decline in annual sales as cost-conscious customers deferred purchasing its pricier home fragrances and personal care products.
La-Z-Boy (NYSE: LZB ) stock fell 1.6% after the furniture manufacturer said the industry will remain "challenged," with a potential seasonal boost.
WeWork (NYSE: WE ) stock fell 5.1% after the New York Stock Exchange suspended trading in the workspace provider's warrants.
Tesla (NASDAQ: TSLA ) stock fell 2.6% after a report by Business Insider said the EV manufacturer has lowered the production target of its German plant to 4,350 a week in July and August after hitting 5,000 a week in March and plans to reduce it further.
Stellantis (NYSE: STLA ) stock fell 0.5% after Bloomberg News reported that the auto giant is exploring options to partner with a Chinese electric vehicle maker as it tries to expand its presence in the world's largest auto market.
Apellis Pharmaceuticals (NASDAQ: APLS ) stock soared 26.8% after the biopharmaceutical company provided a key safety update about its injection kits and the rare events of retinal vasculitis related to its eye drug, Syfovre.
AMC Entertainment (NYSE: AMC ) stock fell 7.5%, continuing to drop after the approval of a rescue deal that will allow the deeply indebted cinema chain to issue more shares.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.